ArrePath
PrivateLast Round
VC Round
Jun 23, 2025
Total Funding Raised
$24.97M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
ArrePath is a biotechnology company that operates a drug discovery platform intended to develop antimicrobial resistance therapies.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Medical Imaging
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ArrePath Comparables
Compare ArrePath with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Stoked Bio Inc. | 86% | |
| Phare Bio | 79% | |
| Terray Therapeutics | 76% |
ArrePath Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 23, 2025 | ||||
| Grant | Apr 2, 2025 | ||||
| Grant | Nov 19, 2024 | ||||
| Seed | Mar 3, 2022 |
ArrePath Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| PTX Capital | Seed |
| Nor'easter Ventures | VC Round, Seed |
| Boehringer Ingelheim | VC Round, Seed |
| PACE (Pathways to Antimicrobial Clinical Efficacy) | Grant |
| CARB-X | Grant |
| Viva BioInnovator | Seed |
| Ab Magnitude Ventures Group | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 163% MoM.
- Jul 24, 2026
Monthly visitors increased 30% MoM.
ArrePath Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ArrePath's valuation, stock price, and market status.
Is ArrePath a public or private company?
ArrePath is a private company.
What is the current stock price of ArrePath?
ArrePath is a private company with no public stock price. No recent secondary market data is available.
How much is ArrePath worth (valuation)?
Valuation information for ArrePath is not publicly available.
Can I buy ArrePath stock?
ArrePath shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ArrePath's last funding round?
ArrePath's most recent funding round was VC Round on June 23, 2025.
Who are the main investors in ArrePath?
Key investors in ArrePath include Boehringer Ingelheim, InnoSpark Ventures, Insight Partners.
Will ArrePath IPO soon?
No public IPO plans have been announced for ArrePath.
How can I track ArrePath secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ArrePath's secondary market activity and sign up for updates.